Durham, NC, United States of America

Chester F Hassman, Iii


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chester F Hassman, III: A Pioneer in Neurokinin A Antagonists

Introduction: Chester F Hassman, III is an esteemed inventor located in Durham, NC, recognized for his contributions to the field of pharmacology. His innovative approach focuses on Neurokinin A antagonists, which have significant implications for various medical conditions. With a single patent to his name, Hassman’s work is a testament to the potential of targeted pharmaceutical interventions.

Latest Patents: Hassman holds a patent for Neurokinin A antagonists, which are derivatives of the naturally occurring neurokinin A. This innovative approach involves modifying the amide bond that connects the two amino acids present at the carboxy terminal end. The effectiveness of these antagonists is confirmed through conventional competitive binding and biochemical assays, as well as physiological tests. The application of these derivatives in various conditions where neurokinin A plays a pivotal role is also highlighted in his patent.

Career Highlights: Chester F Hassman, III is associated with Merrell Pharmaceuticals, Inc., a company that engages in the development of effective pharmaceuticals. His work in this organization indicates a strong commitment to advancing medical science and improving patient outcomes. Through his innovative research, he has carved a niche in the pharmaceutical industry.

Collaborations: Throughout his career, Hassman has collaborated with notable colleagues, including Stephen H Buck and Scott L Harbeson. These collaborations signify the collaborative nature of research and development in the pharmaceutical field, where pooling expertise is crucial for successful innovations.

Conclusion: Chester F Hassman, III’s innovative work on Neurokinin A antagonists showcases the importance of targeted therapies in modern medicine. His contributions continue to impact the landscape of pharmacology, offering hope for individuals affected by conditions linked to neurokinin A. As a dedicated inventor, Hassman exemplifies the spirit of innovation that drives advancement in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…